These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 32673447)
1. Buprenorphine Medication for Opioid Use Disorder: A Study of Factors Associated With Postpartum Treatment Retention. Ray-Griffith S; Tharp E; Coker JL; Catlin D; Knight B; Stowe ZN Am J Addict; 2021 Jan; 30(1):43-48. PubMed ID: 32673447 [TBL] [Abstract][Full Text] [Related]
2. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails. Sufrin C; Kramer CT; Terplan M; Fiscella K; Olson S; Voegtline K; Latkin C JAMA Netw Open; 2022 Jan; 5(1):e2144369. PubMed ID: 35050354 [TBL] [Abstract][Full Text] [Related]
3. The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder. Krans EE; Bobby S; England M; Gedekoh RH; Chang JC; Maguire B; Genday P; English DH Addict Behav; 2018 Nov; 86():124-129. PubMed ID: 29884421 [TBL] [Abstract][Full Text] [Related]
4. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance. Klaman SL; Isaacs K; Leopold A; Perpich J; Hayashi S; Vender J; Campopiano M; Jones HE J Addict Med; 2017; 11(3):178-190. PubMed ID: 28406856 [TBL] [Abstract][Full Text] [Related]
5. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. O'Connor AB; Collett A; Alto WA; O'Brien LM J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660 [TBL] [Abstract][Full Text] [Related]
6. Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder. Schiff DM; Nielsen TC; Hoeppner BB; Terplan M; Hadland SE; Bernson D; Greenfield SF; Bernstein J; Bharel M; Reddy J; Taveras EM; Kelly JF; Wilens TE Am J Obstet Gynecol; 2021 Oct; 225(4):424.e1-424.e12. PubMed ID: 33845029 [TBL] [Abstract][Full Text] [Related]
7. Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder. Wilder C; Lewis D; Winhusen T Drug Alcohol Depend; 2015 Apr; 149():225-31. PubMed ID: 25735465 [TBL] [Abstract][Full Text] [Related]
8. "You have to take this medication, but then you get punished for taking it:" lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period. Schiff DM; Work EC; Muftu S; Partridge S; MacMillan KDL; Gray JR; Hoeppner BB; Kelly JF; Greenfield SF; Jones HE; Wilens TE; Terplan M; Bernstein J J Subst Abuse Treat; 2022 Aug; 139():108765. PubMed ID: 35341614 [TBL] [Abstract][Full Text] [Related]
9. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study. Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128 [TBL] [Abstract][Full Text] [Related]
10. Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy. Mittal L; Suzuki J Subst Abus; 2017; 38(3):261-264. PubMed ID: 26672650 [TBL] [Abstract][Full Text] [Related]
11. Association of methadone dose with substance use and treatment retention in pregnant and postpartum women with opioid use disorder. Wilder CM; Hosta D; Winhusen T J Subst Abuse Treat; 2017 Sep; 80():33-36. PubMed ID: 28755770 [TBL] [Abstract][Full Text] [Related]
12. Treatment of Opioid Use Disorder in Pregnant Women via Telemedicine: A Nonrandomized Controlled Trial. Guille C; Simpson AN; Douglas E; Boyars L; Cristaldi K; McElligott J; Johnson D; Brady K JAMA Netw Open; 2020 Jan; 3(1):e1920177. PubMed ID: 32003816 [TBL] [Abstract][Full Text] [Related]
13. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women. Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191 [TBL] [Abstract][Full Text] [Related]
14. Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence. Coker JL; Catlin D; Ray-Griffith S; Knight B; Stowe ZN Drug Alcohol Depend; 2018 Nov; 192():146-149. PubMed ID: 30253377 [TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison. Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment of opioid use disorder in pregnancy. Rodriguez CE; Klie KA Semin Perinatol; 2019 Apr; 43(3):141-148. PubMed ID: 30755340 [TBL] [Abstract][Full Text] [Related]
17. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Jones HE; Finnegan LP; Kaltenbach K Drugs; 2012 Apr; 72(6):747-57. PubMed ID: 22512363 [TBL] [Abstract][Full Text] [Related]
18. The Lived Experiences of Pregnant and Parenting Women in Recovery Toward Medication Treatment for Opioid Use Disorder. Titus-Glover D; Shaya FT; Welsh C; Roane L Subst Use Addctn J; 2024 Jul; 45(3):367-377. PubMed ID: 38254261 [TBL] [Abstract][Full Text] [Related]
19. Breastfeeding Intention Compared With Breastfeeding Postpartum Among Women Receiving Medication-Assisted Treatment. Yonke N; Maston R; Weitzen S; Leeman L J Hum Lact; 2019 Feb; 35(1):71-79. PubMed ID: 29723483 [TBL] [Abstract][Full Text] [Related]
20. Benzodiazepine withdrawal in pregnant women with opioid use disorders: An observational study of current clinical practices at a tertiary obstetrical hospital. Gopalan P; Moses-Kolko E; Valpey R; Shenai N; Smith E Gen Hosp Psychiatry; 2019; 57():29-33. PubMed ID: 30669023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]